ClinicalTrials.Veeva

Menu

Efficacy and Safety of 675-nm Laser for Dorsal Hand Rejuvenation

M

Mahidol University

Status

Not yet enrolling

Conditions

Wrinkle

Treatments

Device: Redtouch

Study type

Interventional

Funder types

Other

Identifiers

NCT06486727
Si 488/2024

Details and patient eligibility

About

This study aimed to evaluate efficacy and safety of 675-nm laser for dorsal hand rejuvenation in Thai patients. Twenty-six subjects aged 50 to 65 years diagnosed with wrinkle and solar lentigines on both dorsums of hands were included and treated with RedTouch for 3 times every 4 weeks. Then, they were follow up at 3 and 6 months after the final treatment. The measurement of 5-point Global Aesthetic Improvement Scale scores by physicians and subjects were conducted. Moreover, pigmentation level, wrinkle and texture were also recored using Antera. Elasticity was measured using Cutometer.

Full description

RedTouch parameter included Moveo, power 5 W, Energy/DOT 500 mJ/DOT, then Standard, power 4 W, spacing 2000 μm, 1 pass per side.

Enrollment

26 estimated patients

Sex

All

Ages

50 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects diagnosed with wrinkles and solar lentigines on both dorsum of hands

Exclusion criteria

  • Pregnant or lactation
  • Sugjects with a history of allergy to near-infrared wavelength or photosensitizing agents
  • Subjects who have been treated with any kind of energy-based device on both dorsum of hands 6 months prior to the inclusion
  • Subjects who have been injected with filler, or platelet-rich plasma on both dorsum of hands on their faces 6 months prior to the inclusion
  • Active skin infections
  • History of hypertrophic scars or keloids

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

26 participants in 1 patient group

675-nm laser (RedTouch)
Experimental group
Description:
Paramete: Moveo, power 5 W, Energy/DOT 500 mJ/DOT then Standard, power 4 W, spacing 2000 μm, 1 pass per side for 4 times with 4-week interval
Treatment:
Device: Redtouch

Trial contacts and locations

0

Loading...

Central trial contact

Woraphong Manuskiatti, MD; Supisara Wongdama, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems